+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Merck & Co., Inc. - logo

Merck & Co., Inc. is a global healthcare company with operations in more than 140 countries. It offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus and other diseases. The company has collaboration agreements with Adaptimmune Therapeutics plc and Agenus; and a research agreement with Proteros Biostructures. Founded in 1891, it is headquartered in Kenilworth, New Jersey.

5' Nucleotidase - Pipeline Review, H1 2020 - Product Thumbnail Image

5' Nucleotidase - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 109 Pages
  • Global
From
From
From
From
Biliary Tumor - Pipeline Insight, 2025 - Product Thumbnail Image

Biliary Tumor - Pipeline Insight, 2025

  • Report
  • April 2025
  • 180 Pages
  • Global
From
Peritoneal cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Peritoneal cancer - Pipeline Insight, 2025

  • Report
  • April 2025
  • 180 Pages
  • Global
From
Nasal Drug Delivery Technology Market Report 2023-2033 - Product Thumbnail Image

Nasal Drug Delivery Technology Market Report 2023-2033

  • Report
  • April 2023
  • 397 Pages
  • Global
From
From
From
Thymus Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Thymus Cancer - Pipeline Insight, 2025

  • Report
  • April 2025
  • 60 Pages
  • Global
From
Soft Tissue Sarcoma - Pipeline Insight, 2025 - Product Thumbnail Image

Soft Tissue Sarcoma - Pipeline Insight, 2025

  • Report
  • April 2025
  • 280 Pages
  • Global
From
Nasopharyngeal Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Nasopharyngeal Cancer - Pipeline Insight, 2025

  • Report
  • April 2025
  • 80 Pages
  • Global
From
Larynx Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Larynx Cancer - Pipeline Insight, 2025

  • Report
  • April 2025
  • 60 Pages
  • Global
From
Nasopharyngeal Neoplasms - Pipeline Insight, 2025 - Product Thumbnail Image

Nasopharyngeal Neoplasms - Pipeline Insight, 2025

  • Report
  • April 2025
  • 60 Pages
  • Global
From
From
From
Loading Indicator